Представляем вам новый выпуск Инвестиционного дайджеста, в котором собраны основные бизнес-новости столицы за прошедший месяц. 

Среди главных тем выпуска:

  • Российский и зарубежный бизнес продолжает инвестировать в Москву
  • В Москве открыли новый онкоцентр по концессии
  • Инвестор вложит 2,8 млрд руб. в строительство нового завода в столице
  • Деловая активность в Москве вернулась к докризисному уровню
  • 246 помещений можно арендовать у города по льготной ставке

Полная версия Инвестиционного дайджеста Москвы и его видеоверсия, а также архив выпущенных ранее обзоров доступны в разделе «Пресс-центр» на Инвестиционном портале Москвы.

Здесь же, на Инвестпортале Москвы, можно оформить подписку на дайджест и получать его ежемесячно на указанную электронную почту.

RELATED MATERIALS

In more detail
10 Jul
First Russia’s Complete Industrial Area Development Contract Signed in Moscow
In more detail
06 Jul
Technopolis Moscow SEZ Resident Will Launch Production of Remote Pregnancy Management Devices
In more detail
06 Jul
Moscow Is #1 in Electronic Services Quality ranking by Ministry of Economic Development
Interview with TV-Centre
Bolshevichka – Hundred Years of Success
For almost a century now, the enterprise has maintained its brand at a high level and modern technologies and contracts with leading world companies are promoting its continued growth and competitiveness. The Bolshevichka story began back in the 1920s, with the factory starting up in 1929. One of the first workshops was that manufacturing jackets and trousers, as well as coats. It employed 250 workers. The factory was located on the territory of the Perlovs’ former tea-packing plant. During the war, Bolshevichka produced greatcoats, trench coats and reefer jackets for the Red Army and was then honoured to receive an order to make all the uniforms for the Victory Parade.
Merck
Merck Company does not need to be introduced: more than three centuries of presence at the global health care market, life science and high-tech materials developing speak for themselves. CEO of Merck Life Science in Russia and the CIS Heinz Schmidt told in an interview to investmoscow.ru about the company's mission in our country and innovation laboratory work in the capital.
All topics